V407: Minimally invasive surgery for the treatment of benign prostatic hyperplasia

Video

Introduction and Objectives
Minimally invasive approaches for benign prostatic hyperplasia are replacing the gold standard open surgical approach, featuring the same results with lower morbidity. In this video, we present laparoscopic and robotic-assisted simple prostatectomy (SP) using expraperitoneal transvesical or Millin approaches.

Methods
We present 4 consecutive patients who underwent either laparoscopic or robotic-assisted SP for benign prostatic hyperplasia. The estimated prostate volume in the transrectal ultrasonography was 98, 121, 132 and 140 mL. The latter had 27 centimetric bladder calculi; he therefore underwent laparoscopic extraperitoneal transvesical SP. The other patients had robotic-assisted transvesical SP, laparoscopic and robotic-assisted extraperitoneal Millin SP, respectively.

Results
The operation time, blood loss, duration of hospitalization, and duration of drain placement was 90, 120, 110 and 90 minutes; 300, 200, 500 and 400 cc; 5, 5, 4 and 4 days; 6, 5, 3 and 2 days for laparoscopic (conventional and robotic-assisted) transvesical SP and laparoscopic (conventional and robotic-assisted) Millin SP,

Conclusions
Laparoscopic (conventional or robotic-assisted) simple prostatectomy is a feasible method with low morbidity and improved postoperative outcomes.

Funding: None